Bausch reported quarterly earnings but eht stock fell ~ 7% intra-day. Sell on news, it seems. Despite the dip, $BHC's results are excellent for BHC and investors. Looking back a year ago, the original guidance for 2018 vs the new guidance for 2019 compares as follows:Guidance given in FEB 2018 for 2018Full-Year Revenues in the range of $8.10 – $8.30 billionFull-Year Adjusted EBITDA (non-GAAP) in the range of $3.05 – $3.20 billionThe actual results for 2018 wereRevenues of $8.380 BillionAdjusted EBITDA (non-GAAP)1 of $3.474 BillionSo for 2018 they beat the midpoint guidance for Revenue and EBITDA by 2.2% and 11.4%If we apply those same bats to today's 2019 estimates we are looking at8.578 Billion Revenue in 20193.810 Billion EBITDABHC stock is approaching 'buy' territory again.Related: $TEVA, $AGN are in value multiples too.